Umeclidinium inhaler
Incruse, Rolufta
Begutachtet von Sid DajaniZuletzt aktualisiert von Michael Stewart, MRPharmSLast updated 14. Sept. 2024
Erfüllt die Anforderungen des Patienten Richtlinien des Patienten
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Audio-Version
- Add to preferred sources on Google
Umeclidinium is prescribed to help ease the symptoms of cough, wheeze and breathlessness in adults with chronic obstructive pulmonary disease (COPD).
Make sure you know how to use the inhaler device properly. Ask your nurse, doctor or pharmacist to show you, if you are unsure.
Use the inhaler once every day.
At a glance
Umeclidinium is an inhaler used to improve airflow in people with chronic obstructive pulmonary disease (COPD).
It works by opening up the air passages in your lungs, helping to relieve symptoms like cough and breathlessness.
You use this long-acting inhaler once each day, and its effects last for 24 hours.
This inhaler is not for sudden breathlessness; it is a long-term treatment.
Common side-effects can include headache, constipation, dry mouth, or a cough.
Inform your doctor if you have prostate problems, glaucoma, a heart condition, or liver issues before starting.
If your symptoms worsen or you need your reliever inhaler more, contact your doctor or nurse.
In diesem Artikel:
Video picks for Atemtherapie und Atemwegspflege
Lesen Sie unten weiter
About umeclidinium inhaler
Art des Medikaments | Ein antimuskarinisches Bronchodilatator |
Verwendet für | Chronisch obstruktive Lungenerkrankung (COPD) |
Auch genannt | Incruse Ellipta®; |
Verfügbar als | An inhaler device |
Umeclidinium belongs to the group of medicines known as antimuscarinic bronchodilators. It is given to improve the air flow to your lungs. It works by opening up the air passages in your lungs so that air can flow into your lungs more freely.
Umeclidinium can be helpful in relieving symptoms of chronisch obstruktive Lungenerkrankung (COPD). In this condition, the air flow to the lungs is restricted and this causes symptoms such as cough, wheeze and breathlessness. You will have been prescribed umeclidinium to help reduce these symptoms. It is a long-acting inhaler, which means that its effects last for 24 hours, so you only need to use it once each day. It is not a rescue treatment for sudden breathlessness.
Umeclidinium is available in an inhaler on its own (Incruse®), or in combination with vilanterol (Anoro®), or vilanterol and Fluticason (Trelegy®). For information on combination products, please refer to the manufacturer's leaflet provided with your medicine.
Before using umeclidinium
Zurück zum InhaltSome medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start using umeclidinium it is important that your doctor knows:
If you have problems with your prostate gland, or if you have any difficulty passing urine.
Wenn Sie eine Augenerkrankung namens Glaukom haben.
If you have a heart condition, or an unusual heart rhythm.
If you have any problem with the way your liver works.
Wenn Sie schwanger sind oder stillen.
If you are taking any other medicines or using any other inhalers. This includes any medicines you are taking which are available to buy without a prescription, as well as herbal and complementary medicines.
Wenn Sie jemals eine allergische Reaktion auf ein Medikament hatten.
Lesen Sie unten weiter
How to use umeclidinium (Incruse Ellipta)
Zurück zum InhaltBefore you start the treatment, read the manufacturer's printed information leaflet from inside the pack. It will give you more information about umeclidinium, diagrams to remind you how to use the inhaler device, and a full list of side-effects which you may experience.
Follow your doctor's instructions carefully and make sure you know how to use the inhaler device properly. If you are not sure what to do, please ask your nurse, doctor or pharmacist to show you.
Use the inhaler device once each day. Open the inhaler by sliding down the mouthpiece cover until you hear a 'click'. Breathe out (away from the inhaler) and then close your lips around the inhaler mouthpiece. Breathe in slowly and hold this breath for 3-4 seconds (take care not to cover the air vents with your fingers as you do this). Remove the inhaler from your mouth and breathe out again, slowly. Close the inhaler cover. The inhaler contains 30 doses, and you will see the number on the counter reduce by one each time you use the inhaler.
Try to use the inhaler at the same time each day, as this will help you to remember to use it regularly. If you do forget at your usual time, use it as soon as you remember. If you do not remember until the following day, leave out the missed dose - do not take two doses together to make up for a forgotten dose.
Das Beste aus Ihrer Behandlung herausholen
Zurück zum InhaltTreatment with umeclidinium is usually long-term so you should continue to use it unless you are advised otherwise by your doctor. If you are currently using any other inhalers or nebulisers to help your breathing, please discuss with your doctor if there are any of these that you should no longer use. This is because you should not use any other antimuscarinic bronchodilator as well as umeclidinium.
Versuchen Sie, Ihre regelmäßigen Termine bei Ihrem Arzt einzuhalten. So kann Ihr Arzt Ihren Zustand regelmäßig überprüfen.
If you find that your symptoms are becoming worse or that you need to use a reliever inhaler more regularly, contact your doctor or nurse for advice straightaway.
COPD is usually caused by smoking, so the most important treatment is to stop smoking. Smoking causes irritation and damage to the lungs and will make your condition worse. Speak with your doctor or practice nurse for further advice if you are having difficulty in stopping smoking.
People with COPD who exercise regularly tend to have improved breathing and a better quality of life. If you are not used to exercise, a daily walk is a good start if you are able to do this. Speak with your doctor about what level of activity will help your breathing and keep you as fit as possible.
If you are overweight, it may help your breathing if you try to lose weight. This is because being overweight means that you have to work much harder to breathe in to inflate your lungs. A dietician will be able to give you advice on how to eat a healthy diet and lose weight.
Remember to arrange to have your yearly 'flu jabs' each autumn. This will help protect you against influenza and any chest infections that develop due to it.
Lesen Sie unten weiter
Can umeclidinium cause problems?
Zurück zum InhaltAlong with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. The table below contains the most common ones associated with umeclidinium. You will find a full list in the manufacturer's information leaflet supplied with your medicine. The unwanted effects often improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following continue or become troublesome.
Common umeclidinium side-effects (these affect fewer than 1 in 10 people) | Was kann ich tun, wenn ich das erlebe? |
Kopfschmerzen | Trinken Sie viel Wasser und bitten Sie Ihren Apotheker, ein geeignetes Schmerzmittel zu empfehlen. Wenn die Kopfschmerzen anhalten, informieren Sie Ihren Arzt |
Verstopfung | Drink plenty of water and try to eat a balanced diet with plenty of fruit and vegetables |
Dry or sore mouth | Versuchen Sie, zuckerfreien Kaugummi zu kauen oder zuckerfreie Bonbons zu lutschen |
Cough, sore throat, nose and throat irritation or infection, a fast heartbeat, urine infection | Ask in a pharmacy for advice on over-the-counter remedies. If any side-effects become troublesome, speak with your doctor |
If you experience any other symptoms which you think may be due to your medicine, please speak with your doctor or pharmacist for further advice.
How to store umeclidinium
Zurück zum InhaltBewahren Sie alle Medikamente außerhalb der Reichweite und Sicht von Kindern auf.
An einem kühlen, trockenen Ort aufbewahren, fern von direkter Hitze und Licht.
Once opened, discard the desiccant sachet and keep the Incruse® Ellipta inhaler in its tray in order to protect it from moisture.
Discard the Incruse® Ellipta inhaler six weeks after first opening the tray. It may help to write the date you opened the tray on to the pharmacy label.
Wichtige Informationen über alle Medikamente
Zurück zum InhaltWichtige Informationen über alle Medikamente
Verwenden Sie niemals mehr als die vorgeschriebene Dosis. Wenn Sie vermuten, dass Sie oder jemand anderes eine Überdosis dieses Medikaments eingenommen haben könnte, gehen Sie in die Notaufnahme Ihres örtlichen Krankenhauses. Nehmen Sie den Behälter mit, auch wenn er leer ist.
Wenn Sie Medikamente kaufen, fragen Sie einen Apotheker, ob sie sicher mit Ihren anderen Medikamenten eingenommen werden können.
Wenn Sie sich einer Operation oder einer zahnärztlichen Behandlung unterziehen, informieren Sie die Person, die die Behandlung durchführt, über die Medikamente, die Sie einnehmen.
Dieses Medikament ist für Sie. Geben Sie es niemals an andere Personen weiter, auch wenn deren Zustand ähnlich erscheint wie Ihrer.
Bewahren Sie keine abgelaufenen oder unerwünschten Medikamente auf. Bringen Sie sie zu Ihrer örtlichen Apotheke, die sie für Sie entsorgt.
Wenn Sie Fragen zu diesem Medikament haben, fragen Sie Ihren Apotheker.
Berichten Sie Nebenwirkungen eines Medikaments oder Impfstoffs
Wenn Sie Nebenwirkungen bemerken, können Sie diese online über die Yellow Card website.

Unsicher beim Mischen von Medikamenten?
Überprüfen Sie mögliche Wechselwirkungen zwischen Medikamenten, Nahrungsergänzungsmitteln und Lebensmitteln, bevor Sie sie zusammen einnehmen.
Häufig gestellte Fragen
How does umeclidinium work to help my breathing?
Umeclidinium is an antimuscarinic bronchodilator. It works by opening up the air passages in your lungs, allowing air to flow in more freely. This helps to improve the air flow and relieve symptoms of chronic obstructive pulmonary disease (COPD) like cough, wheezing, and breathlessness.
Is umeclidinium a 'rescue' inhaler for sudden breathlessness?
No, umeclidinium is a long-acting inhaler, meaning its effects last for 24 hours. You use it once daily to help manage your COPD symptoms over time. It is not designed to be used as a rescue treatment for sudden or acute breathlessness.
What should I do if I forget to use my umeclidinium inhaler?
If you forget to use your inhaler at your usual time, use it as soon as you remember. However, if you don't remember until the following day, skip the missed dose. Do not take two doses together to compensate for a forgotten dose.
Can I use other inhalers or nebubilsers while I am using umeclidinium?
You should discuss with your doctor if there are any other inhalers or nebulisers you should no longer use. This is because you should not use any other antimuscarinic bronchodilator alongside umeclidinium.
What lifestyle changes can I make to help my COPD alongside using umeclidinium?
Stopping smoking is the most important step, as smoking irritates and damages the lungs, worsening your condition. Regular exercise, even a daily walk, can improve breathing and quality of life. If you are overweight, losing weight can help your breathing as it reduces the effort needed to inflate your lungs. Also, remember to get your yearly 'flu jab' in autumn to protect against influenza and related chest infections.
Will umeclidinium cause me to have a dry mouth or cough?
Yes, dry or sore mouth, and cough, are common side-effects of umeclidinium, affecting fewer than 1 in 10 people. For a dry mouth, you can try chewing sugar-free gum or sucking sugar-free sweets. If these or any other side-effects become troublesome, you should speak with your doctor or pharmacist.
How quickly does umeclidinium expire once I open the packaging?
Once you open the tray that contains the Incruse® Ellipta inhaler, you should discard the inhaler after six weeks. It can be helpful to write the date you opened the tray on the pharmacy label to remember this.
Weiterführende Literatur und Referenzen
- Manufacturer's PIL, Incruse® Ellipta 55 micrograms inhalation powder, pre-dispensed; GlaxoSmithKline UK, The electronic Medicines Compendium. Dated January 2024.
- Medikamente Komplett BNF 89. Ausgabe; Britische Ärztevereinigung und Königliche Pharmazeutische Gesellschaft von Großbritannien, London.
Lesen Sie unten weiter
About the authorView full bio

Michael Stewart, MRPharmS
Manager für die Überprüfung von Beipackzetteln – Auftragnehmer, Apotheker
BPharm (Hons), MRPharmS
Michael ist ein Gemeindapotheker, der in den Midlands und South Yorkshire praktiziert und über mehr als 20 Jahre Erfahrung in der Beratung zu Medikamenten und medizinischen Bedingungen verfügt. Er hat einen starken Hintergrund in der Gesundheitsausbildung, da er Schulungskurse für Apothekenteams und Mitarbeiter von Pflegeeinrichtungen, einschließlich Krankenschwestern, erstellt und durchgeführt hat. Er hat auch zu Apothekenbeiräten für das Management von geringfügigen Erkrankungen in der Gemeinschaft beigetragen.
About the reviewer

Sid Dajani
Sultan Dajani qualified at the London School of Pharmacy in 1994 and became the youngest elected member of the Royal Pharmaceutical Society council since its founding in 1842.
Artikelverlauf
Die Informationen auf dieser Seite wurden von qualifizierten Klinikern verfasst und begutachtet.
Nächste Überprüfung fällig: 12. Sept. 2027
14. Sept. 2024 | Neueste Version

Fragen, teilen, verbinden.
Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
By subscribing you accept our Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.